As the continues to Spread Around the world, and Research are ScRambling for Answers about What TPYES of drug regimens Help Slow or STOP the illness. 

But Whilst Gummint Have Already Been cavalier about announcing Potentials treatments, at least one -born doctor Wanter to run Triers on Canabinoids to Find out if the can Help COVID-19 Patients reduce Inflame and Boosting They Immune Sub-systems.

“What we know medical the Course of the LiteraTure and the Less-experienced we’ve had in CANADA the Exaannum is That There are KnowledgeABLEness anti-inflammatory Properties That Canabinoids Have — Canabinoids Being the Ingredients That come the plant,” Dr. Mohan Cooray, president and CEO of the physician-led online medical Cannalogue told The Torontonian Sun

“On top of That, we know a medical Standpoint That these Ingredients Have Immunomodulation Properties, Meaning That They Augment the Immune Sub-system to make it better… and we’ve Seen this in Illness as Crohn’s disease, Reumatism arthritis, and Sclerotal That medical as a occurring immunomodulator.”

In the Shukan since COVID-19 bregan Spreading across North America, legal sales Have skyrocketed, but science-minded Professionality Have largely recommended Abstaining as the Crises continues. Since is a illness, Smoking of any kind Irritations the Pulmo and Potentialsly exacerbate symptoms. Likewise, health Offical and Expertise in the US Have Already spent time rebuking zealous sellers Touts CBD and THC as untested cure-alls. 

But Whilst most Expertise agree That consuming via Medible or topicals is safer Smoking or E-Cigarettes in the face of COVID-19, Research Dislike Dr. Cooray are Still That he or will be ABLE to the of Canabinoids on in an Officialis — and not Anecdata — setting.

Unfortunately, Despite Dr. Cooray’s push, as of Presses time, Offical at Health CANADA Have not yet any Triers involving Canabinoids and COVID-19 treatment.

Follow on Twitter

Can Cannabinoids COVID-19 Symptoms? -born Wanter to Find Out

Leave a Reply

Your email address will not be published. Required fields are marked *